Please note that assistive links (commonly known as "skip to links") are used throughout this site. These links are not well-supported by some mobile devices. If you are encountering difficulty using these links, please navigate around these links, or access the site on a desktop browser.
Skip to the primary content of this page Skip to the footer of this page

Q1-2022 Dental Services Update

Skip to the end of the Expertise Menu

Q1-2022 Dental Services Update

The DSO market continued to experience significant activity in Q1-2022. Notable transactions include the sale of dentist-owned practices to established DSOs, the formation of new DSOs by private equity investors, and the exits of investor-owned DSOs.

Across these three transaction types, Provident has noted a continued acceleration in specialty dental consolidation. In early 2022, Shore Capital Partners formed a new OMFS-focused DSO, OMS360, and completed a transaction with Community OFS, a multi-state oral surgery practice. Additionally, Blue Sea Capital invested in SIMKO Specialty Dental, which provides Orthodontic and Pediatric DSO services, and Spark Dental Management acquired Children’s Dental Health.

While larger platform transactions are becoming more common, the volume of small and mid-sized, dentist-owned practice sales remains high both across general and specialty dental.

Provident expects that the proven success of investment across the DSO spectrum, consistent volume of practice transactions, and investor demand for quality practices will drive continued market activity and valuations.

To print and download the full Dental Services Update report, please click below…

[holo_button icon=”/wp-content/uploads/2022/04/Q1-2022-Dental-Newsletter-vF.pdff” link=”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]

 

Sources: SEC Filings; Company Press Releases, and Reports; IBISWorld; Capital IQ; PHP Estimates and Research. This document has been compiled with publicly available information. Provident Healthcare Partners, LLC makes no guarantee of its accuracy or completeness. No data or statement should be construed to be a recommendation for the purchase, sale, or retention of any security.